Page last updated: 2024-09-04

ezetimibe and sphingosine kinase

ezetimibe has been researched along with sphingosine kinase in 1 studies

Compound Research Comparison

Studies (ezetimibe)	Trials (ezetimibe)	Recent Studies (post-2010) (ezetimibe)	Studies (sphingosine kinase)	Trials (sphingosine kinase)	Recent Studies (post-2010) (sphingosine kinase)
2,484	563	1,465	1,660	4	978

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ali-Rahmani, F; Connor, JR; Huang, MA; Lee, SY; Schengrund, CL	1

Other Studies

1 other study(ies) available for ezetimibe and sphingosine kinase

Article	Year
C282Y-HFE gene variant affects cholesterol metabolism in human neuroblastoma cells. PloS one, 2014, Volume: 9, Issue:2 Topics: Alleles; Androstenes; Azetidines; Cell Line, Tumor; Cell Survival; Cholesterol; Ezetimibe; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Variation; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Iron; Membrane Proteins; Neuroblastoma; Oxidoreductases; Phenotype; Phosphotransferases (Alcohol Group Acceptor); Risk Factors; Simvastatin; Sphingolipids	2014

Article

Year

C282Y-HFE gene variant affects cholesterol metabolism in human neuroblastoma cells.

PloS one, 2014, Volume: 9, Issue:2

Topics: Alleles; Androstenes; Azetidines; Cell Line, Tumor; Cell Survival; Cholesterol; Ezetimibe; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Variation; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Iron; Membrane Proteins; Neuroblastoma; Oxidoreductases; Phenotype; Phosphotransferases (Alcohol Group Acceptor); Risk Factors; Simvastatin; Sphingolipids

2014